Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › TX › DALLAS › TOPCARE MEDICAL GROUP INC

TOPCARE MEDICAL GROUP INC

NPI: 1285016758 · DALLAS, TX 75251 · Pediatrics Physician · NPI assigned 06/22/2015

$160.36M
Total Medicaid Paid
8,433,773
Total Claims
6,901,976
Beneficiaries
187
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialSAENZ, ALVARO (CEO)
Parent OrganizationTOPCARE MEDICAL GROUP INC
NPI Enumeration Date06/22/2015

Related Entities

Other providers sharing the same authorized official: SAENZ, ALVARO

ProviderCityStateTotal Paid
TOPCARE MEDICAL GROUP INC DALLAS TX $42.63M
TOPCARE MEDICAL PA IRVING TX $561.39

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 24,262 $583K
2019 41,713 $986K
2020 397,507 $6.31M
2021 1,591,965 $32.62M
2022 1,971,256 $35.40M
2023 2,349,279 $44.41M
2024 2,057,791 $40.06M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 848,508 783,437 $31.43M
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 853,615 785,171 $23.00M
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 535,599 509,166 $17.44M
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) 235,403 231,955 $15.35M
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) 226,622 222,350 $13.79M
90460 Immunization administration through 18 years of age via any route, first or only component 1,274,860 604,459 $11.33M
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) 159,518 156,177 $10.89M
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) 161,579 151,919 $9.87M
87400 655,520 311,911 $4.84M
99429 162,103 158,589 $3.99M
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 310,815 174,073 $3.77M
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 318,647 303,934 $3.13M
96110 Developmental screening, with scoring and documentation, per standardized instrument 258,469 193,766 $1.62M
99381 15,708 15,398 $1.07M
90461 305,418 250,439 $855K
99499 8,510 8,040 $853K
87807 106,915 100,668 $842K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc 17,354 16,378 $835K
99383 9,016 8,864 $723K
99204 Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 8,614 8,171 $547K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 27,036 26,294 $537K
99382 5,198 4,963 $419K
99203 Office or other outpatient visit for the evaluation and management of a new patient, low complexity 9,777 8,953 $368K
99384 3,950 3,768 $351K
99000 43,229 40,796 $259K
96160 172,830 168,063 $252K
0071A 6,718 6,653 $223K
G8510 Screening for depression is documented as negative, a follow-up plan is not required 29,963 28,065 $191K
0072A 5,410 5,381 $180K
83655 24,091 23,308 $174K
99222 Initial hospital care, per day, moderate complexity 1,457 1,424 $132K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 9,164 8,565 $99K
0001A 3,423 3,392 $97K
99395 Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years 1,139 1,113 $75K
99238 Hospital discharge day management, 30 minutes or less 1,405 1,373 $73K
97169 5,949 5,821 $72K
0002A 2,604 2,587 $70K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 2,326 1,892 $61K
87428 1,818 1,668 $47K
87631 343 284 $32K
90472 Immunization administration, each additional vaccine (list separately) 4,043 2,407 $32K
92567 2,683 2,525 $27K
G0402 Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment 1,171 1,151 $26K
90834 Psychotherapy, 45 minutes with patient 433 290 $26K
81003 19,223 18,128 $24K
99050 2,202 2,062 $24K
85018 20,648 19,908 $24K
99231 Subsequent hospital care, per day, straightforward or low complexity 654 543 $21K
87811 Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) 733 706 $20K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 2,509 2,280 $20K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 2,139 2,078 $18K
99215 Prolong outpt/office vis 277 245 $15K
94375 633 605 $14K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 1,677 1,450 $12K
0054A 357 349 $12K
90651 92,061 90,639 $12K
0081A 358 345 $12K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 365 300 $11K
96380 907 885 $11K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 1,264 1,251 $11K
90619 13,238 13,086 $9K
90677 39,783 39,229 $8K
0052A 276 276 $7K
90620 11,915 11,637 $7K
0051A 237 236 $6K
94760 12,079 11,544 $5K
0082A 147 145 $5K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 1,294 1,228 $4K
83036 Hemoglobin; glycosylated (A1C) 905 878 $4K
0074A 122 115 $3K
17250 43 41 $3K
90686 201,359 196,831 $3K
87070 785 737 $3K
84443 Thyroid stimulating hormone (TSH) 249 238 $2K
85027 481 445 $2K
99239 Hospital discharge day management, more than 30 minutes 27 27 $2K
0003A 68 67 $2K
94010 114 109 $2K
83013 87 85 $2K
92551 50,677 49,985 $2K
90480 135 134 $2K
90670 83,607 81,758 $2K
G8431 Screening for depression is documented as being positive and a follow-up plan is documented 192 179 $1K
90688 371 209 $1K
97803 503 306 $1K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward 45 45 $1K
88720 340 279 $1K
99460 14 14 $1K
69210 51 50 $1K
90734 27,160 26,601 $891.54
99462 22 13 $840.46
90633 62,512 61,310 $811.45
0004A 36 36 $800.00
90621 4,520 4,453 $781.63
87634 21 19 $640.10
0053A 35 34 $601.20
80061 Lipid panel 62 62 $461.73
86308 156 153 $454.01
0124A 13 13 $452.00
0012A 18 18 $445.72
90474 174 164 $403.05
A7003 Administration set, with small volume nonfiltered pneumatic nebulizer, disposable 2,643 2,401 $366.66
96161 155 149 $266.84
99173 63,080 62,037 $251.29
90716 30,353 29,752 $223.61
J0696 Injection, ceftriaxone sodium, per 250 mg 560 462 $213.70
83014 87 85 $208.95
69209 95 92 $191.79
S9441 Asthma education, non-physician provider, per session 140 134 $174.28
81025 27 26 $168.33
0011A 13 13 $156.20
92552 86 78 $133.92
93000 15 14 $120.70
90648 62,427 60,989 $106.79
92587 102 96 $91.39
80053 Comprehensive metabolic panel 31 28 $89.07
86580 12 12 $85.50
G0447 Face-to-face behavioral counseling for obesity, 15 minutes 311,730 303,651 $68.98
99080 350 339 $55.26
90696 12,412 12,243 $52.50
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg 1,703 1,529 $47.27
85007 24 21 $46.58
90707 29,658 29,051 $45.10
90715 13,013 12,801 $41.51
J7510 Prednisolone oral, per 5 mg 144 135 $40.00
90473 32 32 $28.32
90723 39,043 38,171 $26.79
90656 33,030 32,558 $26.21
3074F 875 811 $25.00
90660 2,348 2,325 $24.68
98960 46 41 $22.45
91307 13,603 12,735 $16.07
99051 1,782 1,649 $16.00
A9150 Non-prescription drugs 646 604 $0.40
90697 32,385 31,874 $0.37
90680 27,864 27,468 $0.25
92558 26 26 $0.17
90681 15,905 15,602 $0.04
90700 9,046 8,825 $0.04
91320 13 13 $0.03
90756 223 223 $0.02
99177 475 472 $0.01
90710 13,610 13,377 $0.00
91300 6,939 6,268 $0.00
3078F 648 614 $0.00
90649 699 658 $0.00
G9920 Screening performed and negative 30 30 $0.00
90713 311 297 $0.00
G8483 Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) 3,630 3,407 $0.00
S0119 Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) 47 47 $0.00
91308 747 698 $0.00
4274F 1,184 1,035 $0.00
99401 80 72 $0.00
G8482 Influenza immunization administered or previously received 5,152 4,653 $0.00
99001 22 14 $0.00
90380 138 136 $0.00
99490 Ccm add 20min 86 80 $0.00
G9919 Screening performed and positive and provision of recommendations 12 12 $0.00
3725F 14 13 $0.00
99188 14 14 $0.00
94664 29 29 $0.00
91312 15 14 $0.00
3008F 178,074 174,250 $0.00
36416 8,322 7,851 $0.00
97802 861 846 $0.00
91305 1,712 1,668 $0.00
90698 3,250 3,177 $0.00
1030F 456 447 $0.00
96127 168 156 $0.00
99172 200 159 $0.00
4037F 355 349 $0.00
90744 667 647 $0.00
99441 323 322 $0.00
J1100 Injection, dexamethasone sodium phosphate, 1 mg 15 15 $0.00
90381 237 231 $0.00
90647 187 177 $0.00
A7004 Small volume nonfiltered pneumatic nebulizer, disposable 14 12 $0.00
D9630 25 25 $0.00
2016F 149 140 $0.00
1005F 151 142 $0.00
36415 Collection of venous blood by venipuncture 16 14 $0.00
91301 33 33 $0.00
H0033 Oral medication administration, direct observation 35 35 $0.00
82962 40 40 $0.00
87430 14 14 $0.00
91319 13 13 $0.00
90674 14 14 $0.00